| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/28/2007 | EP1767646A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767545A1 GLP-1 (Glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765872A1 Glycosylated immunoglobulin and immunoadhesin comprising the same |
| 03/28/2007 | EP1765854A1 An expression system comprising operably linked rgg gene and gtfg promoter |
| 03/28/2007 | EP1765378A2 Agent capable of downregulating an msf-a-dependent hif-1a anduse thereof in cancer treatment |
| 03/28/2007 | EP1554305B1 Prion protein-binding peptide sequences |
| 03/28/2007 | CN1938334A Combined use of a GLP-1 agonist and gastrin compounds |
| 03/28/2007 | CN1935846A Fusion protein for treating diabetes, and its preparing method and use |
| 03/28/2007 | CN1935840A Human receptor proteins; related reagents and methods |
| 03/28/2007 | CN1307201C Coupled substance between Lidamycin and segments of monoclonal antibody 3G11, 3G11Fab' |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196174 PRO1557 polypeptide encoded by a nucleic acid highly expressed in esophageal and kidney tumors |
| 03/27/2007 | US7196173 PRO1315 polypeptide encoded by a nuclear acid highly expressed in esophageal tumors |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066534 Comprising a polypeptide conjugated to one or more lipid moieties; synthetic; highly soluble; contraceptive agent ; vaccine |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/21/2007 | EP1764372A1 Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1115425B1 Autoantibody inhibitors |
| 03/21/2007 | CN1931878A Platelet aggregation resistant chimeric monoclonal antibody and/or its fragment |
| 03/21/2007 | CN1305898C Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 03/20/2007 | US7193070 Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 03/20/2007 | US7193051 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 03/20/2007 | US7193050 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/20/2007 | US7193046 Polypeptide encoded by a nucleic acid overexpressed in esophageal and lung tumor, and underexpressesd in kidney tumor and melanoma |
| 03/20/2007 | US7193045 Nucleotide sequences coding polypeptide for use in diagnostics biosensors and thrombolytic agents |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192766 Sensor containing molded solidified protein |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192587 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/15/2007 | WO2006059110A3 Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste |
| 03/15/2007 | US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/15/2007 | US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/14/2007 | EP1762623A1 Methods for producing biologically active peptide dimers |
| 03/14/2007 | EP1762619A2 Multiple-tumor aberrant growth genes |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | CN1930189A Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 03/14/2007 | CN1927888A Recombination albumen of GLP-1 and analogue thereof and human lysozyme fusion and application thereof |
| 03/14/2007 | CN1927887A Anti-rabies virus recombination immune toxin and preparation process |
| 03/14/2007 | CN1304427C Angiogenesis inhibiting fusion protein and its use |
| 03/14/2007 | CN1304426C Signal system and elements used therein |
| 03/14/2007 | CN1304425C Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 03/13/2007 | US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | CA2160922C Hiv immunogenic complexes |
| 03/08/2007 | WO2007026961A1 Aδ NERVE FUNCTION INHIBITOR AND PREVENTIVE OR REMEDY FOR NEUROPATHIC PAIN |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054315 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 03/07/2007 | EP1760092A1 System for screening cells for high expression of a protein of interest |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1625160A4 A bioelastomer |
| 03/07/2007 | EP1279677B1 Gd3-mimetic peptides |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | CN1926154A EC SOD and cell transducing EC SOD and use thereof |
| 03/07/2007 | CN1924020A Efficient fusion expression carrier |
| 03/07/2007 | CN1303100C Method for preliminary purification of recombinant human parathormone fusion protein by thermo osmosis shock technology |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186805 Fusion proteins; for inhibition of cognate receptor |
| 03/06/2007 | US7186804 IL-2 fusion proteins with modulated selectivity |
| 03/06/2007 | US7186697 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 03/06/2007 | US7186412 Fusion proteins of Mycobacterium tuberculosis |
| 03/06/2007 | CA2320488C Strategically modified hepatitis b core proteins and their derivatives |
| 03/01/2007 | WO2007023686A1 Novel apoptosis inducing factor and method of inducing apoptosis using the same |